The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 21 July 2003. doi:10.1084/jem.20021825
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 348K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yotsumoto, K.
Right arrow Articles by Shibuya, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yotsumoto, K.
Right arrow Articles by Shibuya, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2003/7/223 $5.00
The Journal of Experimental Medicine, Volume 198, Number 2, 223-233

Paired Activating and Inhibitory Immunoglobulin-like Receptors, MAIR-I and MAIR-II, Regulate Mast Cell and Macrophage Activation

Katsumi Yotsumoto1,2, Yasushi Okoshi1,2, Kazuko Shibuya1,2, Satoshi Yamazaki1,2,3, Satoko Tahara-Hanaoka1,2,3, Shin-ichiro Honda1,2,3, Mitsujiro Osawa1, Asato Kuroiwa5, Yoichi Matsuda5, Daniel G. Tenen6, Atsushi Iwama1,6, Hiromitsu Nakauchi1,4 and Akira Shibuya1,2,3

1 Department of Immunology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
2 Laboratory for Immune Receptor, RIKEN Research Center for Allergy and Immunology, Tsukuba, Ibaraki 305-0034, Japan
3 Precursory Research for Embryonic Science and Technology, Japan Science and Technology Corporation, Tsukuba, Ibaraki 305-8575, Japan
4 Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Tsukuba, Ibaraki 305-8575, Japan
5 Laboratory of Cytogenetics, Division of Bioscience, Graduate School of Environmental Earth Science and Chromosome Research Unit, Faculty of Science, Hokkaido University, Kita-ku, Sapporo 060-0810, Japan
6 Harvard Institute of Medicine, Harvard Medical School, Boston, MA 02115

Address correspondence to Akira Shibuya, Laboratory for Immune Receptor, RIKEN Research Center for Allergy and Immunology, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan. Phone: 81-29-836-9174; Fax: 81-29-836-9175; E-mail: ashibuya{at}md.tsukuba.ac.jp

Immune responses are regulated by opposing positive and negative signals triggered by the interaction of activating and inhibitory cell surface receptors with their ligands. Here, we describe novel paired activating and inhibitory immunoglobulin-like receptors, designated myeloid-associated immunoglobulin-like receptor (MAIR) I and MAIR-II, whose extracellular domains are highly conserved by each other. MAIR-I, expressed on the majority of myeloid cells, including macrophages, granulocytes, mast cells, and dendritic cells, contains the tyrosine-based sorting motif and the immunoreceptor tyrosine-based inhibitory motif-like sequences in the cytoplasmic domain and mediates endocytosis of the receptor and inhibition of IgE-mediated degranulation from mast cells. On the other hand, MAIR-II, expressed on subsets of peritoneal macrophages and B cells, associates with the immunoreceptor tyrosine-based activation motif-bearing adaptor DAP12 and stimulates proinflammatory cytokines and chemokine secretions from macrophages. Thus, MAIR-I and MAIR-II play important regulatory roles in cell signaling and immune responses.

Key Words: ITAM • ITIM • innate immunity • DAP12 • myeloid cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS